The loss of balance between proinflammatory and anti-inflammatory factors leads to the activation of NF-κB, TNFα, NLR, and TLR pathways to expand the range of inflammation and promote the development of IBD (Figure 3). Here, NFKB1 is linked to inflammatory bowel disease.